Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CollPlant Ltd.

www.collplant.com

Latest From CollPlant Ltd.

Pacts In Medtech: November/December 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life-sciences deals, this new bimonthly Pacts In Medtech column pulls up notable technology alliances, R&D partnerships and commercial collaborations. This month we highlight deals announced in November and December 2016.

Deals Commercial

Deals Shaping the Medical Industry, December 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in November 2016.

Deals BioPharmaceutical

Execs On The Move, November 2014

Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.

Medical Device BioPharmaceutical

Beyond INFUSE: Spine Community Searches For Answers, Alternatives

Medtronic's INFUSE bone morphogenetic protein is the only product in the musculoskeletal industry that has changed the bar in terms of bone healing, and it is under fire for complications related to off-label use. As regulators and payors crack down on INFUSE and hospitals restrict access to the product, surgeons are seeking alternatives and there are a number of companies lining up to fill the void

Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • Medical Devices
    • Biomaterials
  • Pharmaceuticals
  • Therapeutic Areas
  • Dermatology
  • Musculoskeletal & Connective Tissue Disorders
  • Wound Healing & Tissue Repair
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Middle East
      • Israel
  • Parent & Subsidiaries
  • CollPlant Ltd.
  • Senior Management
  • Yehiel Tal, CEO
    Eran Rotem, CFO
    Nadav Orr, PhD, VP, R&D
    Revital Mandil-Levin, PhD, Chief Bus. Dev. Officer
    Oded Shoseyov, PhD, CSO
  • Contact Info
  • CollPlant Ltd.
    Phone: (972) 73-232-5600
    Weizmann Science Park
    3 Sapir St.
    P.O. Box 4132 Ness Ziona, 74140
    Israel
Advertisement
Advertisement
UsernamePublicRestriction

Register